Flossbach Von Storch SE Acquires Shares of 3,021,324 Ralliant Corporation $RAL

Flossbach Von Storch SE bought a new position in Ralliant Corporation (NYSE:RAL) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,021,324 shares of the company’s stock, valued at approximately $222,460,000. Ralliant comprises about 1.0% of Flossbach Von Storch SE’s portfolio, making the stock its 27th largest position. Flossbach Von Storch SE owned approximately 2.73% of Ralliant as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of RAL. Dunhill Financial LLC bought a new position in shares of Ralliant during the 2nd quarter valued at $25,000. Global Retirement Partners LLC purchased a new stake in Ralliant during the second quarter valued at approximately $35,000. Danske Bank A S bought a new position in Ralliant in the fourth quarter worth approximately $25,000. Persistent Asset Partners Ltd bought a new position in Ralliant in the second quarter worth approximately $37,000. Finally, Allworth Financial LP boosted its stake in shares of Ralliant by 134.4% during the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after acquiring an additional 293 shares during the last quarter.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. TD Cowen increased their target price on shares of Ralliant from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Friday, July 31st. Evercore assumed coverage on shares of Ralliant in a research report on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 price target for the company. BMO Capital Markets initiated coverage on shares of Ralliant in a research note on Monday, July 20th. They issued a “market perform” rating and a $78.00 price objective for the company. Weiss Ratings reiterated a “sell (d)” rating on shares of Ralliant in a research report on Friday, July 31st. Finally, Barclays raised their target price on shares of Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a research note on Wednesday, May 13th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $75.70.

Ralliant Trading Down 4.2%

NYSE RAL opened at $66.56 on Thursday. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. The company has a market capitalization of $7.36 billion, a price-to-earnings ratio of -6.13, a price-to-earnings-growth ratio of 2.58 and a beta of 1.60. The company’s 50-day simple moving average is $69.02 and its two-hundred day simple moving average is $55.79.

Ralliant (NYSE:RAL) last posted its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.05. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.The company had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Equities analysts forecast that Ralliant Corporation will post 2.87 EPS for the current fiscal year.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a $0.05 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. Ralliant’s dividend payout ratio is -1.84%.

Insider Transactions at Ralliant

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of the stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the transaction, the chief executive officer owned 251,967 shares in the company, valued at approximately $18,088,710.93. This represents a 4.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of Ralliant stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the sale, the senior vice president owned 31,668 shares in the company, valued at approximately $2,280,096. The trade was a 16.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.42% of the company’s stock.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.